Stefanie Reif

First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas

Amita Patnaik, Leonard J. Appleman, Anthony W. Tolcher et al. · Annals of Oncology · 2016 · 236 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Population pharmacokinetics–pharmacodynamics of alemtuzumab (Campath^®) in patients with chronic lymphocytic leukaemia and its link to treatment response

Diane R. Mould, Andreas Baumann, Jens Kuhlmann et al. · British Journal of Clinical Pharmacology · 2007 · 113 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Effect of grapefruit juice intake on etoposide bioavailability

Stefanie Reif, M. Nicolson, D. Bisset et al. · European Journal of Clinical Pharmacology · 2002 · 77 citations

Pharmacy, Nutritional Sciences, Pharmacokinetics +4

Feasibility of intraventricular administration of etoposide in patients with metastatic brain tumours

Gudrun Fleischhack, Stefanie Reif, Carola Hasan et al. · British Journal of Cancer · 2001 · 58 citations · Full text

Medicine, Oncology, Pharmacology +13

Pharmacokinetics and Safety of Gadobutrol-Enhanced Magnetic Resonance Imaging in Pediatric Patients

Gabriele Hahn, Ina Sorge, Bernd Gruhn et al. · Investigative Radiology · 2009 · 52 citations

Medicine, Pharmacokinetics, Radiology +17